AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 37 filers reported holding AC IMMUNE SA in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $175,000 | +71.6% | 22,079 | +64.5% | 0.01% | +50.0% |
Q1 2021 | $102,000 | -83.5% | 13,418 | -88.0% | 0.00% | -92.9% |
Q2 2019 | $620,000 | +30.0% | 111,754 | +18.3% | 0.06% | +21.7% |
Q1 2019 | $477,000 | +107.4% | 94,466 | +288.1% | 0.05% | +35.3% |
Q4 2018 | $230,000 | -28.1% | 24,342 | -39.1% | 0.03% | +6.2% |
Q3 2018 | $320,000 | – | 39,960 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 11,297,911 | $55,925,000 | 5.88% |
Prosight Management, LP | 1,248,453 | $6,180,000 | 3.43% |
PA Capital LLC | 76,257 | $377,000 | 0.37% |
Artal Group S.A. | 1,000,000 | $4,950,000 | 0.20% |
Temasek Holdings (Private) Ltd | 2,614,095 | $12,940,000 | 0.10% |
COHEN LAWRENCE B | 13,350 | $66,000 | 0.04% |
Tekla Capital Management LLC | 171,813 | $850,000 | 0.04% |
Athanor Capital, LP | 108,540 | $537,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 28,600 | $142,000 | 0.02% |
APPLETON PARTNERS INC/MA | 11,525 | $57,000 | 0.01% |